Browsing by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
 

Showing results 77096 to 77115 of 206973 < previous   next >
bulletin_1997_75(3)_177-189.pdf.jpg
Inherited thrombophilia : memorandum from a Joint WHO/International Society of Thrombosis and Haemostasis Meeting
Joint WHO/International Society of Thrombosis and Haemostasis Meeting (1995 : Geneva, Switzerland) ( 1997 )
WHO_HGN_ISTH_WG_95.5.pdf.jpg
Inherited thrombophilia : report of a Joint WHO/International Society of Thrombosis and Haemostasis (ISTH) Meeting
Joint WHO/International Society of Thrombosis and Haemostasis Meeting (1995: Geneva, Switzerland); WHO Human Genetics Programme ( 1995 )
9789241511773-eng.pdf.jpg
Inheriting a sustainable world? Atlas on children’s health and the environment
World Health Organization ( 2017 )
9241591560.pdf.jpg
Inheriting the world : the atlas of children's health and the environment / Bruce Gordon, Richard Mackay, Eva Refuess
Gordon, Bruce; Mackay, Richard; Rehfuess, Eva; World Health Organization. Dept. of Protection of the Human Environment ( 2004 )
emhj_2000_6_2_3_425_431.pdf.jpg
Inhibition of luminol-dependent chemiluminescence of human granulocytes by low doses of inorganic mercury
Al Hashimi, A.H.M.; Mohammad, F.H.; Al Krawi, E.A. Abbass ( 2000 )
Abstract

HgCl2, added in vitro to human granulocytes in whole blood, caused a marked inhibitory effect on the luminol-dependent chemiluminescence induced by BaS04 crystals in suspension of these cells. The effect was both dose- and time-dependent when BaS04 was used to stimulate the oxidative burst in granulocytes. Incubation with the highest concentration of HgCl2 used [10 mmol/L], however, did not cause disruption of the membranes of granulocytes. The effect of HgCl2 on the granulocytes was irreversible following washing of the HgCl2-treated cells with phosphate buffered saline. HgCl2 did not affect chemiluminescence produced when luminol was excited by oxidative hydrogen peroxide in a cell-free medium. These results suggest that some of the toxicity of HgCl2 may be greater than mediated by an action on the phagocytic immune system

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG
Fruth, Uli; McShane, Helen; Tanner, Rachel; Manjaly, Zita-Rose; Harris, Stephanie; Silver, Richard F; Kampmann, Beate; Brennan, Michael J; Satti, Iman; Dockrell, Hazel M; Barker, Lew; Walker, K Barry; Meyer, Joel; Wallis, Robert S; Hoft, Dan; Fletcher, Helen A ( 2013-08-28 )
Abstract

Despite the widespread use of the Mycobacterium bovis BCG vaccine, there are more than 9 million new cases of tuberculosis (TB) every year, and there is an urgent need for better TB vaccines. TB vaccine candidates are selected for evaluation based in part on the detection of an antigen-specific gamma interferon (IFN-γ) response. The measurement of mycobacterial growth in blood specimens obtained from subjects immunized with investigational TB vaccines may be a better in vitro correlate of in vivo vaccine efficacy. We performed a clinical study with 30 United Kingdom adults who were followed for 6 months to evaluate the abilities of both a whole-blood- and a novel peripheral blood mononuclear cell (PBMC)-based mycobacterial growth inhibition assay to measure a response to primary vaccination and revaccination with BCG. Using cryopreserved PBMCs, we observed a significant improvement in mycobacterial growth inhibition following primary vaccination but no improvement in growth inhibition following revaccination with BCG (P < 0.05). Mycobacterial growth inhibition following primary BCG vaccination was not correlated with purified protein derivative (PPD) antigen-specific IFN-γ enzyme-linked immunospot (ELISPOT) responses. We demonstrate that a mycobacterial growth inhibition assay can detect improved capacity to control growth following primary immunization, but not revaccination, with BCG. This is the first study to demonstrate that an in vitro growth inhibition assay can identify a difference in vaccine responses by comparing both primary and secondary BCG vaccinations, suggesting that in vitro growth inhibition assays may serve as better surrogates of clinical efficacy than the assays currently used for the assessment of candidate TB vaccines.

dbv28p58.pdf.jpg
Inhibition of the NS2B-NS3 Protease - Towards a Causative Therapy for Dengue Virus Diseases.
Katzenmeier, Gerd ( 2004-12 )
AFR_RC41_R8_por.pdf.jpg
Iniciativa africana para os Medicamentos Essenciais
Comité Regional Africano, 41 ( 1991 )
9275073996.pdf.jpg
Iniciativa Centroamericana de Diabetes (CAMDI): Encuesta de diabetes, hipertensión y factores de riesgo de enfermedades crónica. Villa Nueva, Guatemala 2006
Organización Panamericana de la Salud ( 2007 )
seb11133.pdf.jpg
Iniciativa de atención centrada en los países: informe de la Directora General
Consejo Ejecutivo, 111 ( 2003 )
WHO_POLIO_07.02_ex_summary_spa.pdf.jpg
Iniciativa de Erradicación Mundial de la Poliomielitis: Informe anual 2006: Resumen de orientación
Global Polio Eradication Initiative ( 2007 )
WHO_Polio_08.02_ex_summary_spa.pdf.jpg
Iniciativa de Erradicación Mundial de la Poliomielitis: Informe anual 2007: Resumen de orientación
Global Polio Eradication Initiative ( 2008 )
WHO_POLIO_09.03_ex_summary_spa.pdf.jpg
Iniciativa de Erradicación Mundial de la Poliomielitis: Informe anual 2008: Resumen de orientación
Global Polio Eradication Initiative ( 2009 )
WHO_Polio_10.05_ex_summary_spa.pdf.jpg
Iniciativa de Erradicación Mundial de la Poliomielitis: Informe anual 2009: Resumen de orientación
Global Polio Eradication Initiative ( 2010 )
WHO_POLIO_11.02_ex_summary_spa.pdf.jpg
Iniciativa de Erradicación Mundial de la Poliomielitis: Informe anual 2010: Resumen de orientación
Global Polio Eradication Initiative ( 2011 )
WHO_Polio_06.02_ex_summary_spa.pdf.jpg
Iniciativa de Erradicación Mundial de la Poliomielitis: Informe anual 2005: Resumen de orientación
Global Polio Eradication Initiative ( 2006 )
INICIATIVA_RVL__SEGURIDAD_ALIMENTARIA.pdf.jpg
Iniciativa de Rostros, Voces y Lugares: estrategia de seguridad alimentaria y nutricional comunitaria: Pinzón, Comendador, junio de 2011
Organización Panamericana de la Salud ( 2011-06 )
Abstract

[Extraído del marco de referencia]: La provincia Elías Piña fue creada por la Ley No. 83 del 16 de septiembre de 1942 con el nombre de Provincia San Rafael. Quedó integrada por los municipios Elías Piña y Bánica, con la ciudad de Elías Piña como cabecera. La Ley No. 704 del 12 de abril de 1965 cambió el nombre de la Provincia San Rafael por Provincia La Estrelleta, y la Ley No. 342 del 29 de mayo de 1972 cambió el nombre a Provincia Elías Piña y a la ciudad de Elías Piña le restituyó el nombre con que fue fundada, Comendador. Por su extensión de 1,393.92 kilómetros km² está en el lugar 14o. representando el 2.9% del territorio nacional. Limita al norte con las provincias Dajabón y Santiago Rodríguez, al este con la provincia de San Juan, al Sur con la provincia Independencia y al oeste con la República de Haití. Forma parte de la Región VI del país “El Valle”.

WHO_NMH_NPH_PAH_03.1_spa.pdf.jpg
Iniciativa mundial anual por tu salud, muévete : documento de exposición de conceptos
World Health Organization. Health Education and Health Promotion Unit ( 2003 )
Iniciativa para la formaci'on de agentes de salud de la comunidad en zonas rurales de Hait'i / Gilberte A. Vansintejan y Robin C. Davis
Vansintejan, Gilberte A; Davis, Robin C ( 1986 )
WHO_EOS_96.11_spa.pdf.jpg
La iniciativa PHAST : transformación participativa para la higiene y el saneamiento : un nuevo enfoque para el trabajo comunitario
World Health Organization. Division of Operational Support in Environmental Health ( 1996 )
Showing results 77096 to 77115 of 206973 < previous   next >